Personal information

Other IDs

Scopus Author ID: 6701380393
Loop profile: 288691

Activities

Collapse all

Works (50 of 53)

Items per page:
Page 1 of 2

Hydroxytyrosol Interference with Inflammaging via Modulation of Inflammation and Autophagy

Nutrients
2023-04-05 | Journal article
DOI: 10.3390/nu15071774
Contributors: Francesca Velotti; Roberta Bernini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)

Journal of Clinical Medicine
2022-12-30 | Journal article
DOI: 10.3390/jcm12010304
Contributors: Francesca Velotti; Lara Costantini; Nicolò Merendino
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Perspectives on Populus spp. (Salicaceae) bud extracts as antioxidant and anti-inflammatory agents

Natural Product Research
2022-03-19 | Journal article
DOI: 10.1080/14786419.2021.1896512
Contributors: Elisa Pannucci; Donatella D’Eliseo; Francesca Ieri; Annalisa Romani; Luca Santi; Roberta Bernini; Maurizio Sabatti; Francesca Velotti
Source: check_circle
Crossref

Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19

Molecules
2021-09-25 | Journal article
DOI: 10.3390/molecules26195803
Contributors: Roberta Bernini; Francesca Velotti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells.

Genes Cancer
2017 | Journal article
DOI: 10.18632/genesandcancer.131
Source: Self-asserted source
Francesca VELOTTI

Cell death in cancer: from benchside research to bedside reality

Frontiers Media SA
2016 | Book
DOI: 10.3389/978-2-88919-838-2
Source: Self-asserted source
Francesca VELOTTI

Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells

Journal of Experimental and Clinical Cancer Research
2016 | Journal article
DOI: 10.1186/s13046-016-0302-6
EID:

2-s2.0-84957456757
Contributors: D'Eliseo, D.; Di Rocco, G.; Loria, R.; Soddu, S.; Santoni, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Omega-3 fatty acid and cancer cell cytotoxicity: implication for multi-targeted cancer therapy

J Clin Med
2016 | Journal article
DOI: 10.3390/jcm5020015
Source: Self-asserted source
Francesca VELOTTI
grade
Preferred source (of 2)‎

Capsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91

Nutrition
2015 | Journal article
DOI: 10.1016/j.nut.2014.05.005
EID:

2-s2.0-84924918442
Contributors: Gilardini Montani, M.S.; D'Eliseo, D.; Cirone, M.; Di Renzo, L.; Faggioni, A.; Santoni, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy

Journal of Medicinal Chemistry
2015 | Journal article
DOI: 10.1021/acs.jmedchem.5b00669
EID:

2-s2.0-84949870604
Contributors: Bernini, R.; Gilardini Montani, M.S.; Merendino, N.; Romani, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Molecular and translational classifications of DAMPs in immunogenic cell death

Frontiers in Immunology
2015 | Journal article
DOI: 10.3389/fimmu.2015.00588
EID:

2-s2.0-84949681065
Contributors: Garg, A.D.; Galluzzi, L.; Apetoh, L.; Baert, T.; Birge, R.B.; Bravo-San Pedro, J.M.; Breckpot, K.; Brough, D.; Chaurio, R.; Cirone, M. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Consensus guidelines for the detection of immunogenic cell death

OncoImmunology
2014 | Journal article
DOI: 10.4161/21624011.2014.955691
EID:

2-s2.0-84923247523
Contributors: Kepp, O.; Senovilla, L.; Vitale, I.; Vacchelli, E.; Adjemian, S.; Agostinis, P.; Apetoh, L.; Aranda, F.; Barnaba, V.; Bloy, N. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells

Cell Stress and Chaperones
2013 | Journal article
DOI: 10.1007/s12192-013-0422-2
EID:

2-s2.0-84885484745
Contributors: D'Eliseo, D.; Manzi, L.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Dietary ω-3 polyunsaturated fatty acid DHA: A potential adjuvant in the treatment of cancer

BioMed Research International
2013 | Journal article
DOI: 10.1155/2013/310186
EID:

2-s2.0-84878720719
Contributors: Merendino, N.; Costantini, L.; Manzi, L.; Molinari, R.; D'Eliseo, D.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Naturally occurring hydroxytyrosol: Synthesis and anticancer potential

Current Medicinal Chemistry
2013 | Journal article
DOI: 10.2174/092986713804999367
EID:

2-s2.0-84877979324
Contributors: Bernini, R.; Merendino, N.; Romani, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Docosahexaenoic acid inhibits invasion of human RT112 urinary bladder and PT45 pancreatic carcinoma cells via down-modulation of granzyme B expression

Journal of Nutritional Biochemistry
2012 | Journal article
DOI: 10.1016/j.jnutbio.2011.01.010
EID:

2-s2.0-84859809138
Contributors: D'Eliseo, D.; Manzi, L.; Merendino, N.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells

European Journal of Medicinal Chemistry
2011 | Journal article
DOI: 10.1016/j.ejmech.2010.10.028
EID:

2-s2.0-78650516195
Contributors: Bernini, R.; Crisante, F.; Merendino, N.; Molinari, R.; Soldatelli, M.C.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure

Cancer Immunology, Immunotherapy
2011 | Journal article
DOI: 10.1007/s00262-011-1074-7
EID:

2-s2.0-80054099486
Contributors: Molinari, R.; D'Eliseo, D.; Manzi, L.; Zolla, L.; Velotti, F.; Merendino, N.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion

International Journal of Cancer
2010 | Journal article
DOI: 10.1002/ijc.25135
EID:

2-s2.0-77955621496
Contributors: D'Eliseo, D.; Pisu, P.; Romano, C.; Tubaro, A.; De Nunzio, C.; Morrone, S.; Santoni, A.; Stoppacciaro, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses

Journal of Immunology
2008 | Journal article
DOI: 10.4049/jimmunol.180.6.3719
EID:

2-s2.0-44849143705
Contributors: Sartorius, R.; Pisu, P.; D'Apice, L.; Pizzella, L.; Romano, C.; Cortese, G.; Giorgini, A.; Santoni, A.; Velotti, F.; De Berardinis, P.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation

Nutrition and Cancer
2005 | Journal article
DOI: 10.1207/s15327914nc5202_12
EID:

2-s2.0-27644522029
Contributors: Merendino, N.; Loppi, B.; D'Aquino, M.; Molinari, R.; Pessina, G.; Romano, C.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression

American Journal of Pathology
2003 | Journal article
DOI: 10.1016/S0002-9440(10)63910-7
EID:

2-s2.0-0037378554
Contributors: Chopin, D.; Barei-Moniri, R.; Maillé, P.; Le Frère-Belda, M.-A.; Muscatelli-Groux, B.; Merendino, N.; Lecerf, L.; Stoppacciaro, A.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Induction of Apoptosis in Human Pancreatic Cancer Cells by Docosahexaenoic Acid

Annals of the New York Academy of Sciences
2003 | Book
DOI: 10.1196/annals.1299.143
EID:

2-s2.0-1342326774
Contributors: Merendino, N.; Molinari, R.; Loppi, B.; Pessina, G.; D' Aquino, M.; Tomassi, G.; Velotti, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells

Cellular Immunology
2003 | Journal article
DOI: 10.1016/S0008-8749(03)00060-1
EID:

2-s2.0-0038667616
Contributors: Sartorius, R.; D'Apice, L.; Barba, P.; Guardiola, J.; Santoni, A.; Velotti, F.; De Berardinis, P.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder

British Journal of Cancer
1999 | Journal article
DOI: 10.1038/sj.bjc.6690124
EID:

2-s2.0-0033002670
Contributors: Milella, M.; Jacobelli, J.; Cavallo, F.; Guarini, A.; Velotti, F.; Frati, L.; Foà, R.; Forni, G.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Bases et principes de l' immunothérapie locale utilisant le bacille Calmette Guérin dans le carcinome urothélial vésical. Implications pratiques

Progres en Urologie
1998 | Journal article
EID:

2-s2.0-0007778851
Contributors: Chopin, D.; Patard, J.J.; Saint, F.; Bari, R.; Velotti, F.; Abbou, C.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Immune response following intravesical bacillus Calmette-Guerin instillations in superficial madder cancer: A review

Urological Research
1998 | Journal article
DOI: 10.1007/s002400050039
EID:

2-s2.0-0031746868
Contributors: Patard, J.J.; Saint, F.; Velotti, F.; Abbou, C.C.; Chopin, D.K.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Clonality of in situ tumor-infiltrating lymphocytes from human bladder carcinoma

British Journal of Urology
1997 | Journal article
EID:

2-s2.0-33749285750
Contributors: Velotti, F.; Even, J.; Diez, S.G.; Maille, P.; Groux-Muscatelli, B.; Patard, J.-J.; Abbou, C.; Kourilsky, P.; Chopin, D.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Clonality of tumor-infiltrating lymphocytes in human urinary bladder carcinoma

Journal of Immunotherapy
1997 | Journal article
DOI: 10.1097/00002371-199711000-00007
EID:

2-s2.0-0030782391
Contributors: Velotti, F.; Chopin, D.; Gil-Diez, S.; Maille, P.; Abbou, C.C.; Kourilsky, P.; Even, J.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Locoregional IL-2 immunotherapy of bladder cancer

Immunopharmacology and Immunotoxicology
1997 | Journal article
DOI: 10.3109/08923979709038530
EID:

2-s2.0-0031041566
Contributors: Santoni, A.; Velotti, F.; Giuffrida, A.; Santoni, G.; Piccoli, M.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2

European Urology
1995 | Journal article
EID:

2-s2.0-20244379249
Contributors: Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Bossola, P.C.; Cusumano, G.; Vicentini, C.; De Carli, P.; Ruco, L.; Santoni, A.; Cancrini, A. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Trends in bladder cancer immunotherapy

Acta Urologica Italica
1995 | Journal article
EID:

2-s2.0-0028862092
Contributors: Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Vicentini, C.; Miano, L.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Polyethyleneglycol-modified interleukin-2 in the treatment of superficial neoplasia of the bladder: Study in phase IB | INTERLEUCHINA-2 PEGHILATA NEL TRATTAMENTO DELLE NEOPLASIE SUPERFICIALE DELLA VESCICA. STUDIO DI FASE IB

Acta Urologica Italica
1993 | Journal article
EID:

2-s2.0-0027848633
Contributors: Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Vicentini, C.; Miano, R.; Santoni, A.; Ruco, L.; Miano, L.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine‐activated killer cells with NK phenotype (LAK‐NK)

European Journal of Immunology
1992 | Journal article
DOI: 10.1002/eji.1830220426
EID:

2-s2.0-0026602525
Contributors: Velotti, F.; Palmieri, G.; D'Ambrosio, D.; Piccoli, M.; Frati, L.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Intravesical immunotherapy with recombinant interleukin-2 (rIL-2) in low stage bladder cnacer. Study of IB phase | IMMUNOTERAPIA ENDOVESCICALE CON INTERLEUCHINA-2 RICOMBINANTE (RIL-2) NEL CA. VESCICALE DI BASSO STADIO. STUDIO DI FASE IB

Acta Urologica Italica
1992 | Journal article
EID:

2-s2.0-0026956709
Contributors: Tubaro, A.; Velotti, F.; Stoppacciaro, A.; Bossola, P.C.; Cusumano, G.; Scapellato, F.; Galassi, P.; De Carli, P.; Tonelli, V.; Santoni, A. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2)

Pharmacological Research
1992 | Journal article
DOI: 10.1016/1043-6618(92)90595-3
EID:

2-s2.0-0026646664
Contributors: Velotti, F.; Giuffrida, A.; Cippitelli, M.; Stoppacciaro, A.; Tubaro, A.; Ruco, L.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Continuous intra‐arterial administration of recombinant interleukin‐2 in low‐stage bladder cancer. A phase IB study

Cancer
1991 | Journal article
DOI: 10.1002/1097-0142(19910701)68:1<56::AID-CNCR2820680111>3.0.CO;2-Z
EID:

2-s2.0-0026350747
Contributors: Tubaro, A.; Vicentini, C.; Bossola, P.C.; Galassi, P.; Miano, L.; Velotti, F.; Santoni, A.; Pettinato, A.; Morrone, S.; Napolitano, T. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Interleukin-2 lengthens extrajunctional acetylcholine receptor channel open time in mammalian muscle cells

Pflügers Archiv European Journal of Physiology
1991 | Journal article
DOI: 10.1007/BF00371120
EID:

2-s2.0-0025994731
Contributors: Lorenzon, P.; Ruzzier, F.; Caratsch, C.G.; Giovannelli, A.; Velotti, F.; Santoni, A.; Eusebi, F.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Local Activation of Immune Response in Bladder Cancer Patients Treated with Intraarterial Infusion of Recombinant Interleukin-2

Cancer Research
1991 | Journal article
EID:

2-s2.0-0025874802
Contributors: Velotti, F.; Pettinato, A.; Morrone, S.; Piccoli, M.; Frati, L.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

NK and LAK Susceptibility Varies Inversely with Target Cell MHC Class I Antigen Expression in a Rat Epithelial Tumour System

Scandinavian Journal of Immunology
1991 | Journal article
DOI: 10.1111/j.1365-3083.1991.tb03748.x
EID:

2-s2.0-0025971074
Contributors: CARBONE, E.; RACIOPPI, L.; LA CAVA, A.; PORTELLA, G.; VELOTTI, F.; ZAPPACOSTA, S.; FONTANA, S.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Enhancement of lymphocyte proliferation and il-2 receptor expression by a processed form (gm-1/p) of monosialoganglioside GM-1

Immunopharmacology and Immunotoxicology
1990 | Journal article
DOI: 10.3109/08923979009019677
EID:

2-s2.0-0025678263
Contributors: Giuffrida, A.; Morrone, S.; Gismondi, A.; Santoni, G.; Punturieri, A.; Velotti, F.; Cavallo, G.; Tubaro, E.; Piccoli, M.; Frati, L. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus

Brain Research
1990 | Journal article
DOI: 10.1016/0006-8993(90)91331-A
EID:

2-s2.0-0025061972
Contributors: Tancredi, V.; Zona, C.; Velotti, F.; Eusebi, F.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: A phase I study

Annali dell'Istituto Superiore di Sanita
1990 | Journal article
EID:

2-s2.0-0025673699
Contributors: Velotti, F.; Tubaro, A.; Stoppacciaro, A.; Pettinato, A.; Morrone, S.; Bossola, P.; Napolitano, T.; Miano, L.; Ruco, L.; Piccoli, M. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Neoadjuvant immunotherapy with interleukin-2 in patients with early-stage bladder carcinoma. Clinical and immunological aspects | IMMUNOTERAPIA NEOADIUVANTE CON INTERLEUCHINA-2 IN PAZIENTI AFFETTI DA CARCINOMA VESCICALE DI BASSO STADIO. ASPETTI CLINICI ED IMMUNOLOGICI

Acta Urologica Italica
1990 | Journal article
EID:

2-s2.0-0025535733
Contributors: Miano, L.; Tubaro, A.; Vicentini, C.; Galassi, P.; Bossola, P.C.; Scapellato, F.; Velotti, F.; Pettinato, A.; Morrone, S.; Napolitano, T. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Possible role of immunological mechanisms in ochronotic arthropathy

Reumatismo
1990 | Journal article
EID:

2-s2.0-0025293932
Contributors: Aliberti, G.; Velotti, F.; Vecci, E.; Oddo, C.M.; Pettinato Sabatini, A.M.; Pulignano, I.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Granzyme A expression by normal rat natural killer (NK) cells in vivo and by interleukin 2‐activated NK cells in vitro

European Journal of Immunology
1989 | Journal article
DOI: 10.1002/eji.1830190328
EID:

2-s2.0-0024560458
Contributors: Velotti, F.; Palmieri, G.; Morrone, S.; Piccoli, M.; Frati, L.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL

Clinical and Experimental Immunology
1989 | Journal article
EID:

2-s2.0-0024595928
Contributors: Punturieri, A.; Velotti, F.; Piccoli, M.; Herberman, R.B.; Frati, L.; Santoni, A.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli

Immunology
1988 | Journal article
EID:

2-s2.0-0023927292
Contributors: Garcia-Sanz, J.A.; Velotti, F.; Macdonald, H.R.; Masson, D.; Tschopp, J.; Nabholz, M.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Mechanisms involved in the activation and function of natural killer cells

Italian Journal of Medicine
1988 | Journal article
EID:

2-s2.0-0023686293
Contributors: Santoni, A.; Palmieri, G.; Procopio, A.; Velotti, F.; Testi, R.; Morrone, S.; Galli, M.C.; Gismondi, A.; Paolini, R.; Punturieri, A. et al.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier

Granzyme A secretion by normal activated Lyt‐2<sup>+</sup> and L3T4<sup>+</sup> T cells in response to antigenic stimulation

European Journal of Immunology
1987 | Journal article
DOI: 10.1002/eji.1830170804
EID:

2-s2.0-0023266736
Contributors: Velotti, F.; MacDonal, H.R.; Nabholz, M.
Source: Self-asserted source
Francesca VELOTTI via Scopus - Elsevier
Items per page:
Page 1 of 2
How many people are using ORCID?